Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 1

1(14.3%)

Phase 2

1(14.3%)

7Total

N/A(5)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04077151Not ApplicableCompleted

Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Demonstration Project

Role: lead

NCT04769492Not ApplicableRecruiting

#ChopViolence/#ChopHIV

Role: lead

NCT04077138Completed

Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Intervention Development

Role: lead

NCT03652623Phase 1Completed

Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study

Role: lead

NCT05848570Recruiting

Keeping it LITE: Exploring HIV Risk in Vulnerable Youth With Limited Interaction and Digital Health Intervention

Role: lead

NCT01755091Phase 2Completed

Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea

Role: collaborator

NCT02464423Not ApplicableCompleted

Improving Adherence Among HIV+ Rwandan Youth: A TI-CBTe Indigenous Leader Model

Role: lead

NCT02371525Not ApplicableCompleted

Enhancing PrEP in Community Settings (EPIC)

Role: collaborator

NCT02891720Not ApplicableNot Yet Recruiting

Feasibility of an Ingestible Sensor System to Measure PrEP Adherence in YMSM

Role: lead

All 9 trials loaded